Bill Miller
Miller Value Partners
Bill Miller Precigen Inc stake
total: 460
Miller Value Partners PGEN trades
- Total transactions:
- 36
- New positions:
- 2
- Sold out:
- 2
- Added:
- 21
- Reduced:
- 11
- Held since:
- 2023 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2023 Q2
According to 2026 Q1 report, Bill Miller doesn't hold any Precigen Inc (PGEN) shares. To date, the estimated cost basis is nearly $1.06 for "buy" trades and estimated average "sell" price is $1.06. Miller Value Partners first purchased PGEN in 2013 Q4, initially acquiring about 1.17M shares. Bill Miller later completely sold out the position and invested in Precigen Inc again in 2023 Q1. Since the initial investment in Precigen Inc (PGEN), Miller Value Partners has made 35 more transactions.
When did Bill Miller sell Precigen Inc (PGEN)?
Bill Miller sold off the entire Precigen Inc (PGEN) position in 2023 Q2.
When did Bill Miller buy Precigen Inc (PGEN)?
Bill Miller first invested in Precigen Inc (PGEN) in 2013 Q4 at the reported quarter-end price of $23.80 per share.
What's the cost basis of Miller Value Partners's PGEN stake?
The estimated cost basis for Precigen Inc (PGEN) stake is around $1.06 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $1.06
- Weighted AVG sell price:
- $1.06
Bill Miller's historical trades in Precigen Inc
36 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q2
|
0.00%
|
0
|
$1.06
|
|
-100% (-9,503,782)
|
-0.63%
|
|
2023 Q1
|
0.63%
|
9,503,782
|
$1.06
|
$10,074,009
|
new
|
+0.63%
|
|
2022 Q3
|
0.00%
|
0
|
$1.34
|
|
-100% (-5,598,807)
|
-0.42%
|
|
2022 Q2
|
0.42%
|
5,598,807
|
$1.34
|
$7,503,000
|
-12.40% (-792,548)
|
-0.04%
|
|
2022 Q1
|
0.51%
|
6,391,355
|
$2.11
|
$13,485,000
|
-0.66% (-42,583)
|
-0%
|
|
2021 Q4
|
0.84%
|
6,433,938
|
$3.71
|
$23,870,000
|
-20.17% (-1,625,183)
|
-0.21%
|
|
2021 Q3
|
1.37%
|
8,059,121
|
$4.99
|
$40,215,000
|
-12.95% (-1,198,747)
|
-0.16%
|
|
2021 Q2
|
1.57%
|
9,257,868
|
$6.52
|
$60,362,000
|
+1.72% (+156,393)
|
+0.03%
|
|
2021 Q1
|
1.78%
|
9,101,475
|
$6.89
|
$62,709,000
|
+27.58% (+1,967,381)
|
+0.38%
|
|
2020 Q4
|
2.46%
|
$10.20
|
-5.62% (-424,482)
|
|||
|
2020 Q3
|
1.05%
|
$3.50
|
-2.14% (-165,659)
|
|||
|
2020 Q2
|
1.71%
|
$4.99
|
+3.71% (+276,248)
|
|||
|
2020 Q1
|
1.63%
|
$3.40
|
-11.51% (-968,723)
|
|||
|
2019 Q4
|
1.65%
|
$5.48
|
+0.03% (+2,700)
|
|||
|
2019 Q3
|
1.95%
|
$5.72
|
+4.54% (+365,350)
|
|||
|
2019 Q2
|
2.46%
|
$7.66
|
+13.61% (+964,175)
|
|||
|
2019 Q1
|
1.48%
|
$5.26
|
+45.24% (+2,206,810)
|
|||
|
2018 Q4
|
1.45%
|
$6.54
|
+3.64% (+171,125)
|
|||
|
2018 Q3
|
2.64%
|
$17.22
|
-1.27% (-60,575)
|
|||
|
2018 Q2
|
2.50%
|
$13.94
|
-0.89% (-42,875)
|
|||
|
2018 Q1
|
3.16%
|
$15.33
|
+4.93% (+225,825)
|
|||
|
2017 Q4
|
2.29%
|
$11.52
|
+24.84% (+912,175)
|
|||
|
2017 Q3
|
3.21%
|
$19.01
|
-1.21% (-45,000)
|
|||
|
2017 Q2
|
4.07%
|
$24.09
|
+6.58% (+229,575)
|
|||
|
2017 Q1
|
3.58%
|
$19.82
|
+13.25% (+408,100)
|
|||
|
2016 Q4
|
3.98%
|
$24.30
|
+0.14% (+4,400)
|
|||
|
2016 Q3
|
4.91%
|
$28.02
|
+0.10% (+2,950)
|
|||
|
2016 Q2
|
4.88%
|
$24.61
|
-8.20% (-274,250)
|
|||
|
2016 Q1
|
5.63%
|
$33.89
|
+5.60% (+177,375)
|
|||
|
2015 Q4
|
3.66%
|
$30.15
|
+7.63% (+224,700)
|
|||
|
2015 Q1
|
5.04%
|
$45.37
|
+0.09% (+2,600)
|
|||
|
2014 Q4
|
3.17%
|
$27.53
|
+1.86% (+53,800)
|
|||
|
2014 Q3
|
2.28%
|
$18.58
|
+3.09% (+86,425)
|
|||
|
2014 Q2
|
2.83%
|
$25.13
|
+69.66% (+1,150,200)
|
|||
|
2014 Q1
|
1.74%
|
$26.29
|
+40.76% (+478,125)
|
|||
|
2013 Q4
|
1.30%
|
$23.80
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.